WEST PHARMACEUTICAL SERVICES INC (WST) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
WST currently has 72M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 0.27% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 23, 2026 |
10-Q filing | 72.0M shares outstanding |
72M | 0 |
| Jul 24, 2025 |
10-Q filing | 72.2M shares outstanding |
72M | 0 |
| Apr 24, 2025 |
10-Q filing | 72.5M shares outstanding |
73M | 0 |
| Feb 18, 2025 |
10-K filing | 73.0M shares outstanding |
73M | 0 |
| Dec 13, 2024 |
8-K filing: On December 9, 2024, the Board of Directors approved a share repurchase program authorizing the repurchase of up to 550,000 shares of common stock. |
73M | 0 |
| Oct 24, 2024 |
10-Q filing | 72.8M shares outstanding |
73M | 0 |
| Jul 25, 2024 |
10-Q filing | 73.0M shares outstanding |
73M | 0 |
| Apr 25, 2024 |
10-Q filing | 73.5M shares outstanding |
74M | 0 |
| Feb 20, 2024 |
10-K filing | 74.3M shares outstanding |
74M | 0 |
| Oct 26, 2023 |
10-Q filing | 74.3M shares outstanding |
74M | 0 |
| Jul 27, 2023 |
10-Q filing | 74.3M shares outstanding |
74M | 0 |
| Apr 27, 2023 |
10-Q filing | 74.5M shares outstanding |
75M | 0 |
| Feb 21, 2023 |
10-K filing | 74.4M shares outstanding |
74M | 0 |
| Oct 27, 2022 |
10-Q filing | 74.4M shares outstanding |
74M | 0 |
| Jul 28, 2022 |
10-Q filing | 74.4M shares outstanding |
74M | 0 |
| Apr 28, 2022 |
10-Q filing | 74.4M shares outstanding |
74M | 0 |
| Feb 22, 2022 |
10-K filing | 74.4M shares outstanding |
74M | 0 |
| Oct 28, 2021 |
10-Q filing | 74.1M shares outstanding |
74M | 0 |
| Jul 30, 2021 |
10-Q filing | 74.0M shares outstanding |
74M | 0 |
| Apr 30, 2021 |
10-Q filing | 73.9M shares outstanding |
74M | 0 |
| Feb 23, 2021 |
10-K filing | 73.9M shares outstanding |
74M | 0 |
| Dec 09, 2020 |
8-K filing: The Company's Board authorized a share repurchase program for calendar-year 2021 of up to 631,000 shares of the Company's common stock. |
74M | 0 |
| Oct 23, 2020 |
10-Q filing | 73.9M shares outstanding |
74M | 0 |
| Jul 24, 2020 |
10-Q filing | 73.8M shares outstanding |
74M | 0 |
| Apr 24, 2020 |
10-Q filing | 73.9M shares outstanding |
74M | 0 |
| Feb 24, 2020 |
10-K filing | 74.0M shares outstanding |
74M | 0 |